MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts payable
$12,956K
Proceeds from exercises
of options
$908K
Stock-based compensation
$9,033K
Net income (loss)
$5,397K
Non-cash interest on
revenue interest...
-$5,079K
Other non-current
assets
-$3,783K
Depreciation and
amortization
$536K
Amortization of debt issuance
costs
$321K
Interest receivable on
marketable securities
-$24K
Net cash provided by
(used in) operating...
$5,069K
Net cash provided by
financing activities
$44K
Canceled cashflow
$32,060K
Canceled cashflow
$864K
Net (decrease)
increase in cash and cash...
-$38,695K
Canceled cashflow
$5,113K
Proceeds from sale of
marketable securities
$38,558K
Accrued expenses
-$12,319K
Accounts receivable
$6,647K
Prepaid expenses and
other current assets
$4,436K
Inventory
$4,433K
Change in fair value of
warrant liability
-$2,865K
Amortization of premium and
discounts on marketable...
$839K
Contract liabilities
$426K
Non-cash lease expense
-$66K
Unrealized foreign
currency transaction...
$21K
Realized loss (gain) on
marketable securities
$8K
Payments on revenue
interest financing...
$864K
Net cash (used in)
provided by investing...
-$43,636K
Canceled cashflow
$38,558K
Effect of foreign
exchange rate changes on...
-$172K
Purchases of marketable
securities
$82,146K
Purchases of property and
equipment
$48K
Back
Back
Cash Flow
Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. (NUVB)
source: myfinsight.com